These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24108720)

  • 1. The technologically integrated oncosimulator: combining multiscale cancer modeling with information technology in the in silico oncology context.
    Stamatakos G; Dionysiou D; Lunzer A; Belleman R; Kolokotroni E; Georgiadi E; Erdt M; Pukacki J; Rüeping S; Giatili S; d'Onofrio A; Sfakianakis S; Marias K; Desmedt C; Tsiknakis M; Graf N
    IEEE J Biomed Health Inform; 2014 May; 18(3):840-54. PubMed ID: 24108720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'In silico' oncology for clinical decision making in the context of nephroblastoma.
    Graf N; Hoppe A; Georgiadi E; Belleman R; Desmedt C; Dionysiou D; Erdt M; Jacques J; Kolokotroni E; Lunzer A; Tsiknakis M; Stamatakos G
    Klin Padiatr; 2009; 221(3):141-9. PubMed ID: 19437361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An advanced discrete state-discrete event multiscale simulation model of the response of a solid tumor to chemotherapy: Mimicking a clinical study.
    Stamatakos GS; Kolokotroni EA; Dionysiou DD; Georgiadi ECh; Desmedt C
    J Theor Biol; 2010 Sep; 266(1):124-39. PubMed ID: 20515697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico oncology: exploiting clinical studies to clinically adapt and validate multiscale oncosimulators.
    Stamatakos GS; Kolokotroni E; Dionysiou D; Veith C; Kim YJ; Franz A; Marias K; Sabczynski J; Bohle R; Graf N
    Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():5545-9. PubMed ID: 24110993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The "Oncosimulator": a multilevel, clinically oriented simulation system of tumor growth and organism response to therapeutic schemes. Towards the clinical evaluation of in silico oncology.
    Stamatakos GS; Dionysiou DD; Graf NM; Sofra NA; Desmedt C; Hoppe A; Uzunoglu NK; Tsiknakis M
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():6629-32. PubMed ID: 18003545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards in silico oncology: adapting a four dimensional nephroblastoma treatment model to a clinical trial case based on multi-method sensitivity analysis.
    Georgiadi ECh; Dionysiou DD; Graf N; Stamatakos GS
    Comput Biol Med; 2012 Nov; 42(11):1064-78. PubMed ID: 23063290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Web-based workflow planning platform supporting the design and execution of complex multiscale cancer models.
    Sakkalis V; Sfakianakis S; Tzamali E; Marias K; Stamatakos G; Misichroni F; Ouzounoglou E; Kolokotroni E; Dionysiou D; Johnson D; McKeever S; Graf N
    IEEE J Biomed Health Inform; 2014 May; 18(3):824-31. PubMed ID: 24808225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACGT: advancing clinico-genomic trials on cancer - four years of experience.
    Martin L; Anguita A; Graf N; Tsiknakis M; Brochhausen M; Rüping S; Bucur A; Sfakianakis S; Sengstag T; Buffa F; Stenzhorn H
    Stud Health Technol Inform; 2011; 169():734-8. PubMed ID: 21893844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Modular Repository-based Infrastructure for Simulation Model Storage and Execution Support in the Context of
    Christodoulou NA; Tousert NE; Georgiadi EC; Argyri KD; Misichroni FD; Stamatakos GS
    Cancer Inform; 2016; 15():219-235. PubMed ID: 27812280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting clinical trial data drastically narrows the window of possible solutions to the problem of clinical adaptation of a multiscale cancer model.
    Stamatakos GS; Georgiadi EC; Graf N; Kolokotroni EA; Dionysiou DD
    PLoS One; 2011 Mar; 6(3):e17594. PubMed ID: 21407827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the Way to New Horizons: Telemedicine in Oncology.
    Schlag PM
    Oncologist; 1997; 2(2):III-IV. PubMed ID: 10388041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From tumour perfusion to drug delivery and clinical translation of in silico cancer models.
    Hadjicharalambous M; Wijeratne PA; Vavourakis V
    Methods; 2021 Jan; 185():82-93. PubMed ID: 32147442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study on the predictability of acute lymphoblastic leukaemia response to treatment using a hybrid oncosimulator.
    Ouzounoglou E; Kolokotroni E; Stanulla M; Stamatakos GS
    Interface Focus; 2018 Feb; 8(1):20160163. PubMed ID: 29285342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction of hypermatrix and operator notation into a discrete mathematics simulation model of malignant tumour response to therapeutic schemes in vivo. Some operator properties.
    Stamatakos GS; Dionysiou DD
    Cancer Inform; 2009 Oct; 7():239-51. PubMed ID: 20011462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mathematical modeling of cancer progression and response to chemotherapy.
    Sanga S; Sinek JP; Frieboes HB; Ferrari M; Fruehauf JP; Cristini V
    Expert Rev Anticancer Ther; 2006 Oct; 6(10):1361-76. PubMed ID: 17069522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Building a European biomedical grid on cancer: the ACGT Integrated Project.
    Tsiknakis M; Kafetzopoulos D; Potamias G; Analyti A; Marias K; Manganas A
    Stud Health Technol Inform; 2006; 120():247-58. PubMed ID: 16823143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grid cellware: the first grid-enabled tool for modelling and simulating cellular processes.
    Dhar PK; Meng TC; Somani S; Ye L; Sakharkar K; Krishnan A; Ridwan AB; Wah SH; Chitre M; Hao Z
    Bioinformatics; 2005 Apr; 21(7):1284-7. PubMed ID: 15546936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A semantic grid infrastructure enabling integrated access and analysis of multilevel biomedical data in support of postgenomic clinical trials on cancer.
    Tsiknakis M; Brochhausen M; Nabrzyski J; Pucacki J; Sfakianakis SG; Potamias G; Desmedt C; Kafetzopoulos D
    IEEE Trans Inf Technol Biomed; 2008 Mar; 12(2):205-17. PubMed ID: 18348950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.